Ticker Details
Embecta Corp.
IPO Date:	April 1, 2022
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$196.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 2.20%
Avg Daily Range (30 D):	$0.19 | 3.50%
Avg Daily Range (90 D):	$0.20 | 2.45%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	2.38M
Avg Daily Volume (90 D):	1.23M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	129
Avg Trade Size (Sh.) (90 D):	91

Institutional Trades
Total Institutional Trades:	1,561
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$1.12M
Avg Institutional Trade (90 D):	$1.49M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.35M
Avg Closing Trade (30 D):	$1.2M
Avg Closing Trade (90 D):	$1.56M
Avg Closing Volume:	124.46K

News

May 15, 2026 @ 1:00 PM embecta Completes Acquisition of Owen Mumford Hold... Source: Na

May 6, 2026 @ 12:19 AM Why Embecta Stock Plummeted Today Source: Keith Noonan

May 5, 2026 @ 10:30 AM embecta Announces Quarterly Cash Dividend Source: Globe Newswire

Apr 21, 2026 @ 9:00 PM embecta to Report Fiscal Second Quarter Financial ... Source: Na

Mar 19, 2026 @ 3:37 PM Embecta Rallies After UK Firm Deal Worth $200 Mill... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.92	$-.07	$.75
Diluted EPS	$1.89	$-.07	$.74
Revenue	$1.04B	$221.8M	$261.2M
Gross Profit	$645.1M	$127.8M	$161.7M
Net Income / Loss	$111.9M	$-4.1M	$44.1M
Operating Income / Loss	$268.8M	$35M	$83.3M
Cost of Revenue	$397.4M	$94M	$99.5M
Net Cash Flow	$-22.5M	$-10.9M	$-24.9M
PE Ratio